Delivery Order SPE2DB22D1202-SPE2DB25FUNA2

Award Date 12/18/24
Potential Completion Date 1/10/25
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FUNA2
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,254.16 firm-fixed-price delivery order contract is for the supply of XEOMIN 100 unit vials, a specialty pharmaceutical product. The contract has an ultimate completion date of January 10, 2025 and was awarded on December 18, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen's extensive capabilities in pharmaceutical distribution and medical supply procurement have made the company a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems.

Generated 3/19/25, 10:00 AM